Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis

Research output: Contribution to journalReview articlepeer-review

23 Scopus citations

Abstract

Lymphoplasmacytic lymphoma (LPL) represents a distinct type of mature B-cell lymphoma with a substantial subset of cases being associated with Waldenström macroglobulinaemia (WM), defined as primarily bone marrow involvement and the presence of an IgM monoclonal paraprotein. MYD88 L265P mutation, although not specific, is present in the vast majority (>90%) of LPL cases and sheds light on the potential pathogenesis of this disease. This review offers an overview of current knowledge on the pathogenesis, clinical presentations, histological features and immunophenotype of LPL and WM. In addition, the differential diagnosis of LPL and WM from other mature B cell neoplasms is highlighted with a focus on distinction from marginal zone lymphoma and plasma cell neoplasms.

Original languageEnglish (US)
Pages (from-to)6-14
Number of pages9
JournalPathology
Volume52
Issue number1
DOIs
StatePublished - Jan 2020

Keywords

  • Lymphoplasmacytic lymphoma
  • Waldenström macroglobulinaemia
  • diagnosis
  • differential diagnosis
  • pathogenesis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Fingerprint

Dive into the research topics of 'Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis'. Together they form a unique fingerprint.

Cite this